It is estimated that <5% of BRCA1 and BRCA2 carriers among women with BC are identified in Asia due to major gaps in the availability of cancer-specialised genetic counselling (GC) and access to funded genetic testing (GT) in this region. The gene discussed is BRCA2; the disease is cancer.